Substance p antagonism as a novel therapeutic option to enhance efficacy of cisplatin in triple negative breast cancer and protect pc12 cells against cisplatin-induced oxidative stress and apoptosis

Emma Rodriguez, Guangsheng Pei, Sang T. Kim, Alexis German, Prema Robinson

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Substance p antagonism as a novel therapeutic option to enhance efficacy of cisplatin in triple negative breast cancer and protect pc12 cells against cisplatin-induced oxidative stress and apoptosis'. Together they form a unique fingerprint.

Medicine & Life Sciences